Tizanidine

From Wikipedia, the free encyclopedia - View original article

Tizanidine
Systematic (IUPAC) name
5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)benzo[c][1,2,5]thiadiazol-4-amine
Clinical data
Trade namesZanaflex
AHFS/Drugs.commonograph
MedlinePlusa601121
Legal status-only (US)
RoutesOral, Intranasal, Injection
Pharmacokinetic data
Protein binding30%
MetabolismCYP 1A2
Half-life2.54 hours
Identifiers
CAS number51322-75-9 YesY
ATC codeM03BX02
PubChemCID 5487
DrugBankDB00697
ChemSpider5287 YesY
UNII6AI06C00GW YesY
KEGGD08611 YesY
ChEMBLCHEMBL1079 YesY
Synonyms4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-8-thia-7,9-diazabicyclo[4.3.0]nona-2,4,6,9-tetraen-5-amine
Chemical data
FormulaC9H8ClN5S 
Mol. mass253.712 g/mol
 YesY (what is this?)  (verify)
 
Jump to: navigation, search
Tizanidine
Systematic (IUPAC) name
5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)benzo[c][1,2,5]thiadiazol-4-amine
Clinical data
Trade namesZanaflex
AHFS/Drugs.commonograph
MedlinePlusa601121
Legal status-only (US)
RoutesOral, Intranasal, Injection
Pharmacokinetic data
Protein binding30%
MetabolismCYP 1A2
Half-life2.54 hours
Identifiers
CAS number51322-75-9 YesY
ATC codeM03BX02
PubChemCID 5487
DrugBankDB00697
ChemSpider5287 YesY
UNII6AI06C00GW YesY
KEGGD08611 YesY
ChEMBLCHEMBL1079 YesY
Synonyms4-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-8-thia-7,9-diazabicyclo[4.3.0]nona-2,4,6,9-tetraen-5-amine
Chemical data
FormulaC9H8ClN5S 
Mol. mass253.712 g/mol
 YesY (what is this?)  (verify)

Tizanidine (trade names Zanaflex, Sirdalud) is a drug that is used as a muscle relaxant. It is a centrally acting α2 adrenergic agonist. It is used to treat the spasms, cramping, and tightness of muscles caused by medical problems such as multiple sclerosis, ALS, spastic diplegia, back pain, or certain other injuries to the spine or central nervous system. It is also prescribed off-label for migraine headaches, as a sleep aid, and as an anticonvulsant. It is also prescribed for some symptoms of fibromyalgia.[1]

Tizanidine has been found to be as effective as other antispasmodic drugs and has superior tolerability to that of baclofen and diazepam.[2] Tizanidine can be very strong even at the 2 mg dose and may cause hypotension, so caution is advised when it is used in patients who have a history of orthostatic hypotension, or when switching from gel cap to tablet form and vice versa.

Tizanidine can occasionally cause liver damage, generally the hepatocellular type. Clinical trials show that up to 5% of patients treated with tizanidine had elevated liver function test values, though symptoms disappeared upon withdrawal of the drug. Care should be used when first beginning treatment with tizanidine with regular liver tests for the first 6 months of treatment.

Availability[edit]

Tizanidine is supplied as 2 and 4 mg tablets for oral administration, and in gel cap form in doses of 2 mg, 4 mg, and 6 mg.

The tablets are composed of the active ingredient, tizanidine hydrochloride (2.288 mg equivalent to 2 mg tizanidine base and 4.576 mg equivalent to 4 mg tizanidine base), and the inactive ingredients, silicon dioxide colloidal, stearic acid, microcrystalline cellulose and anhydrous lactose.

Interactions[edit]

Concomitant use of tizanidine and moderate or potent CYP1A2 inhibitors is contraindicated. Concomitant use of tizanidine with fluvoxamine, a potent CYP1A2 inhibitor in man, resulted in a 33-fold increase in the tizanidine AUC (plasma drug concentration-time curve).[citation needed] Tizanidine is a potent sedative.[citation needed] It therefore has the potential to interact with other CNS depressants. Alcohol should be avoided, particularly as it can upset the stomach.

It has a Volume of Distribution of 2.6L (Manufacturers notes).

Side effects[edit]

Side effects include dizziness, drowsiness, weakness, nervousness, depression, vomiting, tingling sensation in the arms, legs, hands, and feet, dry mouth, constipation, diarrhea, stomach pain, heartburn, increased muscle spasms, back pain, rash and sweating.[3]

References[edit]

  1. ^ Zanaflex for Fibromyalgia
  2. ^ Kamen, L.; Henney, HR.; Runyan, JD. (Feb 2008). "A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury.". Curr Med Res Opin 24 (2): 425–39. doi:10.1185/030079908X261113. PMID 18167175. 
  3. ^ Tizanidine - PubMed Health